ACAD
41.4
-0.29
-0.70%
AEMD
7
+0.1
+1.45%
APRI
1.87
+0.02
+1.08%
ARNA
4.46
+0.02
+0.45%
ATEC
1.33
-0.06
-4.32%
CNAT
5.04
-0.12
-2.33%
CRXM
0.327
0.00
0.00%
CYTX
0.513
-0.035
-6.3733%
DXCM
80.11
+0.75
+0.95%
GNMK
8.77
-0.14
-1.57%
HALO
22.72
+0.62
+2.81%
ILMN
220.14
+0.07
+0.03%
INNV
0.12
0.00
0.00%
INO
7.77
-0.15
-1.89%
ISCO
0.047
+0.004
+9.0698%
ISIS
55.87
-0.26
-0.46%
LGND
98.15
-0.45
-0.46%
LPTN
0.26
-0.02
-5.49%
MBVX
2.62
-0.09
-3.32%
MEIP
1.74
-0.03
-1.7006%
MNOV
3.95
-0.07
-1.74%
MRTX
31.92
+0.62
+1.98%
MSTX
0.469
-0.012
-2.3958%
NBIX
48.36
+1.05
+2.22%
NUVA
47.32
+0.03
+0.06%
ONCS
6.2
-0.15
-2.36%
ONVO
3.69
-0.05
-1.34%
OREX
4.71
-0.05
-1.05%
OTIC
21.63
-0.46
-2.08%
QDEL
22.62
-0.39
-1.69%
RCPT
198.21
+3.3
+1.69%
RGLS
10.13
-0.07
-0.69%
RMD
55.35
+0.04
+0.07%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.818
-0.005
-0.6197%
SRNE
16.98
+0.3
+1.80%
TROV
9.97
+0.44
+4.6212%
VICL
0.698
-0.002
-0.2858%
ZGNX
12.79
-0.01
-0.08%
ACAD
41.4
-0.29
-0.70%
AEMD
7
+0.1
+1.45%
APRI
1.87
+0.02
+1.08%
ARNA
4.46
+0.02
+0.45%
ATEC
1.33
-0.06
-4.32%
CNAT
5.04
-0.12
-2.33%
CRXM
0.327
0.00
0.00%
CYTX
0.513
-0.035
-6.3733%
DXCM
80.11
+0.75
+0.95%
GNMK
8.77
-0.14
-1.57%
HALO
22.72
+0.62
+2.81%
ILMN
220.14
+0.07
+0.03%
INNV
0.12
0.00
0.00%
INO
7.77
-0.15
-1.89%
ISCO
0.047
+0.004
+9.0698%
ISIS
55.87
-0.26
-0.46%
LGND
98.15
-0.45
-0.46%
LPTN
0.26
-0.02
-5.49%
MBVX
2.62
-0.09
-3.32%
MEIP
1.74
-0.03
-1.7006%
MNOV
3.95
-0.07
-1.74%
MRTX
31.92
+0.62
+1.98%
MSTX
0.469
-0.012
-2.3958%
NBIX
48.36
+1.05
+2.22%
NUVA
47.32
+0.03
+0.06%
ONCS
6.2
-0.15
-2.36%
ONVO
3.69
-0.05
-1.34%
OREX
4.71
-0.05
-1.05%
OTIC
21.63
-0.46
-2.08%
QDEL
22.62
-0.39
-1.69%
RCPT
198.21
+3.3
+1.69%
RGLS
10.13
-0.07
-0.69%
RMD
55.35
+0.04
+0.07%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.818
-0.005
-0.6197%
SRNE
16.98
+0.3
+1.80%
TROV
9.97
+0.44
+4.6212%
VICL
0.698
-0.002
-0.2858%
ZGNX
12.79
-0.01
-0.08%
Home » Archive by Category

Xconomy

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]

Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars

February 9, 2015 – 11:01 am

In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousand flowers bloom. In other words,…

[[Click headline to continue reading.]]

Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars

February 9, 2015 – 11:01 am

In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousand flowers bloom. In other words,…

[[Click headline to continue reading.]]

Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars

February 9, 2015 – 11:01 am

In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousand flowers bloom. In other words,…

[[Click headline to continue reading.]]

Resistance Is Futile: Why That’s A Good Thing In Biomedicine

February 9, 2015 – 1:00 am

Fans of Star Trek: The Next Generation are very familiar with the Borg, a society of cybernetic individuals linked together in a collective mindset. The Borg navigate the universe in cube-shaped…

[[Click headline to continue reading.]]